Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China.
Institute of Traditional Chinese Medicine Pharmacology and Toxicology, Sichuan academy of Chinese Medicine Sciences, Chengdu, China.
Exp Lung Res. 2024;50(1):221-241. doi: 10.1080/01902148.2024.2428939. Epub 2024 Nov 18.
Acute lung injury (ALI) is characterized by severe hypoxemia, reduced lung elasticity, and notable pulmonary edema, often caused by infections and potentially progressing to ARDS. This article explores animal models of ALI and clarifies its main pathogenic mechanisms. we reviewed 20 years of ALI animal model advancements via PubMed, assessing clinical symptoms, histopathology, and reproducibility, and provided guidance on selecting models aligned with ALI pathogenesis. key proinflammatory mediators and interleukins play a significant role in ALI development, though their interactions are not fully understood. Preclinical models are essential for investigating ALI causes and testing treatments. Animal models mimic ALI from sources such as infections, drugs, and I/R events, but differences between mouse and human lungs necessitate careful validation of these findings. A comprehensive strategy is essential to address clinical treatment and drug R&D challenges to prevent severe complications and reduce mortality rates.
急性肺损伤 (ALI) 的特点是严重的低氧血症、肺弹性降低和明显的肺水肿,通常由感染引起,并可能进展为急性呼吸窘迫综合征 (ARDS)。本文探讨了 ALI 的动物模型,并阐明了其主要发病机制。我们通过 PubMed 回顾了 20 年来的 ALI 动物模型进展,评估了临床症状、组织病理学和重现性,并就与 ALI 发病机制相符的模型选择提供了指导。关键的促炎介质和白细胞介素在 ALI 的发展中起着重要作用,尽管它们的相互作用尚未完全清楚。临床前模型对于研究 ALI 的病因和测试治疗方法至关重要。动物模型模拟了感染、药物和 I/R 事件等来源的 ALI,但老鼠和人类肺部之间的差异需要仔细验证这些发现。需要采取综合策略来应对临床治疗和药物研发的挑战,以预防严重并发症和降低死亡率。